Universitätsklinikum Münster

Significance of pulmonary involvement in systemic sclerosis (SSc)- data from the German SSc-network (2018) Kreuter M, Bonella F, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution Registry Research Funding of the German Society of Plastic, Reconstructive and Aesthetic Surgeons (DGPRÄC) and Research Funding Report 2017/2018 (2018) Giunta RE, Moellhoff N, Horch RE, Prantl L, Beier JP, Daigeler A, Dragu A, et al. Journal article Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women (2018) Dittrich R, Kliesch S, Schuering A, Balcerek M, Baston-Buest DM, Beck R, Beckmann M, et al. Journal article Neurointensive care medicine-from where, where to? (2018) Stummer W, Schwab S, Fink GR Journal article Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers (2018) Hamer H, Pfaefflin M, Baier H, Boesebeck F, Franz M, Holtkamp M, Kurlemann G, et al. Journal article Changes of disease characteristics and disease-modifying treatment within one year in the National German MS cohort (2018) Ambrosius B, Hessler N, Antony G, Konig IR, Hoshi MM, Aly L, Luessi F, et al. Conference contribution Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations (2018) Reinhardt A, Stichel D, Schrimpf D, Sahm F, Korshunov A, Reuss DE, Koelsche C, et al. Journal article DNA methylation-based classification of central nervous system tumours (2018) Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, et al. Journal article Metastatic castration-resistant prostate cancer. Use of cabazitaxel taking into consideration current data (2018) Gschwend JE, Albers P, Boegemann M, Goebell P, Heidenreich A, Klier J, Koenig F, et al. Journal article Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study (2018) Huhn K, Bayas A, Doerck S, Frank B, Gerbershagen K, Hellwig K, Kallmann B, et al. Journal article